Recently, according to internal sources, Danaher Corporation has announced the latest appointment: Rosa Chen (Chen Xiaosui), General Manager of Beckman Coulter Clinical Diagnostics in China, has been promoted to President of the China Diagnostics Platform, effective January 1, 2024. It is reported that, in September 2021, Chris Chen joined Danaher; in February 2022, he was appointed as Vice President and General Manager of Beckman Coulter Diagnostics China. Previously, Chris Chen also worked at Johnson & Johnson and Philips. In addition, Chris Chen serves as the Executive Director of the China Association of Medical Equipment, Deputy Chairman of the Laboratory Medicine Branch of the China Association of Medical Equipment, and Deputy Chairman of the Clinical Laboratory Management Branch of the Xiamen Hospital Association. In fact, since Chen Xiaosui joined Danaher, he has always adhered to the concept of "open innovation." Under the influence of policies such as centralized procurement, Chen Xiaosui has flexibly promoted Beckman's in-depth localization development and accelerated the localization process through intelligent transformation strategies. Previously, the IVD Network team was invited to visit Danaher's Medical Diagnostics Platform R&D and Intelligent Manufacturing Base and had in-depth exchanges with five Beckman executives, including Chen Xiaosui. Mr. Li Guangyu, founder of the IVD Network, also expressed high optimism about Beckman's future development "in China, for China." Source:IVD NetworkWorkPatient:So much fuss